Intravenous immunoglobulin treatments for women who suffer from chronic miscarriages reportedly are becoming increasingly popular despite lack of proof that they actually work and a high price tag.
IVIG takes antibodies from the blood of over 100 donors and administers them to alter a woman's immune system, so her body doesn't reject the fetus. Clinical trials are being conducted to test the treatment.

Related Summaries